Ironwood Pharmaceuticals ... (IRWD)
NASDAQ: IRWD
· Real-Time Price · USD
1.07
-0.02 (-1.83%)
At close: Aug 14, 2025, 3:59 PM
1.02
-5.12%
After-hours: Aug 14, 2025, 07:31 PM EDT
-1.83% (1D)
| Bid | 1.02 |
| Market Cap | 174.62M |
| Revenue (ttm) | 317.68M |
| Net Income (ttm) | -31.41M |
| EPS (ttm) | -0.05 |
| PE Ratio (ttm) | -21.5 |
| Forward PE | 2.66 |
| Analyst | Hold |
| Ask | 1.12 |
| Volume | 1,039,826 |
| Avg. Volume (20D) | 2,216,046 |
| Open | 1.08 |
| Previous Close | 1.09 |
| Day's Range | 1.01 - 1.09 |
| 52-Week Range | 0.53 - 5.21 |
| Beta | 0.33 |
About IRWD
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol IRWD
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for IRWD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Ironwood Pharmaceuticals has released their quartely earnings
on Aug 7, 2025:
Next Earnings Release
Ironwood Pharmaceuticals Inc. is scheduled to release its earnings on
Nov 6, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
+9.32%
Ironwood Pharmaceuticals shares are trading higher...
Unlock content with
Pro Subscription
4 months ago
-31.48%
Ironwood Pharmaceuticals shares are trading lower after the company announced that the FDA wants a confirmatory Phase 3 trial to approve apraglutide for short bowel syndrome with intestinal failure.
